Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMed Technology Holdings is a commercial-stage biotech company specializing in precision microbiome analysis and microbiome-based interventions. Their PGut brand offers consumer products and services, and they claim a database of over 10,000 microbiome profiles from across Asia. They provide personalized prebiotic, probiotic, and postbiotic formulations based on DNA test results, and their offerings are distributed via healthcare providers and retail outlets in Hong Kong, with expansion in mainland China, Macau, and Thailand. The company focuses on holistic microbiome health for disease prevention and wellness enhancement[2][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMed Technology Holdings.